Interviews

AJMCtv interviews let you catch up with experts on what's new and important about the changes in healthcare. Where else can a few minutes of your time give you insights from key decision makers - from the clinician, to the health plan leader, to the regulator? AJMCtv interviews give you the close-ups you might not get even if you make it to the conference. When every minute in your day matters, AJMCtv interviews keep you informed.
The US health industry is in the midst of a transformation to a value-outcome system, which is good for a learning health system, explained Lewis G. Sandy, MD, FACP, senior vice president of clinical advancement at UnitedHealth Group.
Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.
Aligning the care delivered with the patient's own desires is the biggest opportunity available to drive costs down while improving quality, according to Marc Boutin, JD, chief executive officer of the National Health Council.
With more than 35,000 people expected to attend the 2015 ASCO Annual Meeting, there are many highly anticipated aspects of the conference; however, Peter P. Yu, MD, FACP, FASCO, president of ASCO and director of Cancer Research at Palo Alto Medical Foundation, highlighted how the society has been going in a different direction with its keynote speaker.
The international representation and participation at the ISPOR 20th Annual Meeting was one of the key aspects of the meeting, held May 18-20 in Philadelphia, Pennsylvania, said Dan Malone, PhD, RPh, incoming president of ISPOR.
The new opioid quality measures by the Pharmacy Quality Alliance are a first step forward for improving use of prescription opioids.
The American Journal of Managed Care's Patient-Centered Oncology Care meeting is an important event for anyone interested in "crossing the chasm" that appears between providers and the rest of the healthcare world, explained Peter P. Yu, MD, president of the American Society of Clinical Oncology.
The industry has seen a lot of progress when it comes to involving patients more and earlier in the research progress, Dan Leonard, president of the National Pharmaceutical Council, said at the Pharmaceutical Quality Alliance's 10th Annual Meeting.

Feature